EWTX Edgewise Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 6, 2026
$41,40
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$14,25rendah 52m
$48,51tinggi 52m
Kapitalisasi Pasar (MRQ)
$4.46B
P/E
-25.7
EPS
$-1.63
lencana Anda
Rentang 52M
$14–$49
Peringkat Analis
BUY
Target Harga
$53
P/E
-25.7
ROE
-30.2%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
EWTX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$41.40
Kapitalisasi Pasar (MRQ)
$4.46B
P/E
-25.7
EPS
$-1.63
ROE
-30.2%
Rentang 52M
$14–$49
EWTX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-1.632020-12-31 → 2025-12-31
Arus Kas Bebas$-144M2021-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | EWTX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -25.7rata-rata 5T ≈-12.2 | ≈-12.2 | · | · | |
| P/B (MRQ) | 10.0rata-rata 5T ≈3.5 | ≈3.5 | 6.5 | Terlalu mahal | |
| Harga / FCF (TTM) | -28.1rata-rata 5T ≈-16.2 | ≈-16.2 | · | · | |
| Harga / Arus Kas (TTM) | -28.2rata-rata 5T ≈-16.7 | ≈-16.7 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 8.5rata-rata 5T ≈3.5 | ≈3.5 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | EWTX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -32.3%rata-rata 5T ≈-26.9% | ≈-26.9% | -20.0% | Lemah | |
| ROE | -30.2%rata-rata 5T ≈-25.1% | ≈-25.1% | -20.8% | Lemah | |
| ROIC | -36.6% | · | -17.6% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | EWTX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 16.2rata-rata 5T ≈21.6 | ≈21.6 | 11.6 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 2.2rata-rata 5T ≈2.4 | ≈2.4 | 5.0 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
2.7%
Laporan Berikutnya
Nov 04, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 6, 2026 | $-0.53 | $-0.48 | -10.6% |
| 31 Maret 2026 | Mei 7, 2026 | $-0.46 | $-0.50 | 7.3% |
| 31 Des. 2025 | $-0.47 | $-0.44 | -5.7% | |
| 30 Sep. 2025 | $-0.39 | $-0.41 | 3.8% | |
| 30 Juni 2025 | $-0.34 | $-0.42 | 19.8% | |
| 31 Maret 2025 | $-0.43 | $-0.44 | 1.7% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $151M | $127M | $91M | $54M | $32M | $15M | |
| SG&A Expense | $40M | $32M | $23M | $18M | $11M | $2M | |
| Operating Expenses | $191M | $159M | $114M | $72M | $43M | $17M | |
| Operating Income | $-191M | $-159M | $-114M | $-72M | $-43M | $-17M | |
| Pretax Income | $-168M | $-134M | $-100M | · | · | · | |
| Income Tax | $4.0K | $3.0K | $4.0K | $0 | $0 | · | |
| Net Income | $-168M | $-134M | $-100M | $-68M | $-43M | $-17M | |
| EPS (Basic) | $-1.63 | $-1.45 | $-1.57 | $-1.26 | $-1.14 | $-23.17 | |
| EPS (Diluted) | $-1.63 | $-1.45 | $-1.57 | $-1.26 | $-1.14 | $-23.17 | |
| Shares (Basic) | 102,930,744 | 92,414,626 | 63,723,600 | 53,593,753 | 37,526,332 | 739,004 | |
| Shares (Diluted) | 102,930,744 | 92,414,626 | 63,723,600 | 53,593,753 | 37,526,332 | 739,004 | |
| EBITDA | $-191M | $-159M | $-114M | $-72M | $-43M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $61M | $42M | $86M | $22M | $16M | $105M | |
| Prepaid Expense | $13M | $5M | $9M | $5M | $3M | $551.0K | |
| Current Assets | $543M | $475M | $327M | $357M | $284M | $130M | |
| PP&E (Net) | $8M | $10M | $10M | $9M | $912.0K | $516.0K | |
| PP&E (Gross) | $15M | $14M | $13M | $10M | $2M | $946.0K | |
| Accum. Depreciation | $7M | $5M | $3M | $1M | $702.0K | $430.0K | |
| Other Non-current Assets | · | $262.0K | $348.0K | $251.0K | $548.0K | $975.0K | |
| Total Assets | $553M | $487M | $340M | $367M | $285M | $131M | |
| Accounts Payable | $6M | $6M | $4M | $6M | $4M | $2M | |
| Accrued Liabilities | $8M | $7M | $6M | $6M | $4M | $2M | |
| Current Liabilities | $27M | $24M | $17M | $17M | $11M | $4M | |
| Capital Leases | $3M | $4M | $4M | $4M | · | · | |
| Other Non-current Liabilities | · | · | · | · | $329.0K | · | |
| Total Liabilities | $30M | $28M | $21M | $20M | $11M | $4M | |
| Common Stock | $10.0K | $9.0K | $7.0K | $6.0K | $5.0K | · | |
| Paid-in Capital | $1.07B | $837M | $563M | $493M | $352M | $727.0K | |
| Retained Earnings | $-546M | $-379M | $-245M | $-145M | $-77M | $-34M | |
| AOCI | $677.0K | $420.0K | $99.0K | $-1M | $-514.0K | · | |
| Stockholders' Equity | $522M | $459M | $319M | $347M | $274M | $-33M | |
| Liabilities + Equity | $553M | $487M | $340M | $367M | $285M | $131M | |
| Shares Outstanding | 106,249,579 | 94,838,466 | 70,453,342 | 63,257,376 | 49,500,308 | 1,009,479 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $35M | $25M | $18M | $11M | $4M | $354.0K | |
| Operating Cash Flow | $-144M | $-109M | $-92M | $-53M | $-34M | $-15M | |
| CapEx | $256.0K | $1M | $6M | $6M | $668.0K | $203.0K | |
| Investing Cash Flow | $-33M | $-185M | $103M | $-71M | $-242M | $-24M | |
| Stock Issued | $187M | $239M | $53M | $129M | · | · | |
| Net Stock Activity | $187M | $239M | $53M | $129M | · | · | |
| Financing Cash Flow | $196M | $249M | $53M | $130M | $186M | $120M | |
| Net Change in Cash | $19M | $-44M | $64M | $6M | $-89M | $81M | |
| Free Cash Flow | $-144M | $-110M | $-98M | $-58M | $-34M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -32.3% | -32.4% | -28.3% | -20.7% | -20.6% | · | |
| ROE | -30.2% | -28.2% | -32.9% | -19.1% | -15.3% | · | |
| ROIC | -36.6% | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 19.9 | 19.9 | 19.5 | 21.5 | 27.0 | · | |
| Quick Ratio | 2.2 | 1.7 | 5.1 | 1.3 | 1.5 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.92 | $4.84 | $4.53 | $5.48 | $5.54 | · | |
| Cash Flow / Share | $-1.40 | $-1.18 | $-1.44 | $-0.98 | $-0.89 | · | |
| Cash / Share | $0.58 | $0.44 | $1.22 | $0.35 | $0.31 | · | |
| EPS (TTM) | $-1.63 | $-1.45 | $-1.57 | $-1.26 | $-1.14 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-168M | $-134M | $-100M | $-68M | $-43M | · | |
| Market Cap | $2.64B | $2.53B | $771M | $566M | $756M | · | |
| P/E | -15.2 | -18.4 | -7.0 | -7.1 | -13.4 | · | |
| P/B | 5.0 | 5.5 | 2.4 | 1.6 | 2.8 | · | |
| P / Tangible Book | 5.0 | 5.5 | 2.4 | 1.6 | 2.8 | · | |
| P / Cash Flow | -18.3 | -23.2 | -8.4 | -10.7 | -22.6 | · | |
| P / FCF | -18.3 | -22.9 | -7.9 | -9.7 | -22.1 | · | |
| Earnings Yield | -6.6% | -5.4% | -14.3% | -14.1% | -7.5% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $48M | $43M | $44M | $37M | $34M | $37M | $36M | $32M | $31M | $28M | $24M | $20M | $20M | $17M | $14M | $12M | |
| SG&A Expense | $14M | $11M | $12M | $9M | $9M | $9M | $9M | $8M | $7M | $7M | $6M | $6M | $6M | $5M | $4M | $4M | |
| Operating Expenses | $62M | $54M | $56M | $47M | $43M | $46M | $46M | $40M | $38M | $35M | $29M | $25M | $26M | $22M | $18M | $16M | |
| Operating Income | $-62M | $-54M | $-56M | $-47M | $-43M | $-46M | $-46M | $-40M | $-38M | $-35M | $-29M | $-25M | $-26M | $-22M | $-18M | $-16M | |
| Net Income | $-57M | $-49M | $-50M | $-41M | $-36M | $-41M | $-40M | $-34M | $-31M | $-29M | $-26M | $-21M | $-23M | $-19M | $-17M | $-16M | |
| EPS (Basic) | $-0.53 | $-0.46 | $-0.47 | $-0.39 | $-0.34 | $-0.43 | $-0.42 | $-0.36 | $-0.34 | $-0.33 | $-0.41 | $-0.34 | $-0.36 | $-0.30 | $-0.34 | $-0.32 | |
| EPS (Diluted) | $-0.53 | $-0.46 | $-0.47 | $-0.39 | $-0.34 | $-0.43 | $-0.42 | $-0.36 | $-0.34 | $-0.33 | $-0.41 | $-0.34 | $-0.36 | $-0.30 | $-0.34 | $-0.32 | |
| Shares (Basic) | 107,669,774 | 107,116,709 | · | 105,492,779 | 104,940,493 | 95,130,053 | · | 93,813,346 | 93,515,356 | 87,567,307 | 63,459,560 | 63,380,430 | 63,265,800 | · | 51,844,904 | 49,622,752 | |
| Shares (Diluted) | 107,669,774 | 107,116,709 | · | 105,492,779 | 104,940,493 | 95,130,053 | · | 93,813,346 | 93,515,356 | 87,567,307 | 63,459,560 | 63,380,430 | 63,265,800 | · | 51,844,904 | 49,622,752 | |
| EBITDA | $-62M | $-54M | · | $-47M | $-43M | $-46M | · | $-40M | $-38M | $-35M | $-29M | $-25M | $-26M | · | $-18M | $-16M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $72M | $33M | $61M | $46M | $43M | $50M | $42M | $45M | $43M | $30M | $33M | $32M | $48M | $22M | $110M | $18M | |
| Prepaid Expense | $6M | $10M | $13M | $11M | $9M | $7M | $5M | $7M | $8M | $9M | $8M | $7M | $5M | $5M | $5M | $5M | |
| Current Assets | $472M | $510M | $543M | $574M | $603M | $443M | $475M | $499M | $519M | $541M | $298M | $317M | $333M | $357M | $370M | $253M | |
| PP&E (Net) | $7M | $7M | $8M | $8M | $9M | $9M | $10M | $10M | $10M | $10M | $11M | $11M | $10M | $9M | $5M | $2M | |
| PP&E (Gross) | $15M | $15M | $15M | $14M | $14M | $14M | $14M | $14M | $13M | $13M | $13M | $13M | $12M | $10M | $6M | $3M | |
| Accum. Depreciation | $8M | $7M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $1M | $1M | $977.0K | $882.0K | |
| Other Non-current Assets | · | · | · | · | · | $695.0K | $262.0K | $262.0K | $262.0K | · | $467.0K | $419.0K | $251.0K | $251.0K | $264.0K | $447.0K | |
| Total Assets | $480M | $519M | $553M | $583M | $613M | $454M | $487M | $511M | $532M | $554M | $311M | $331M | $346M | $367M | $377M | $257M | |
| Accounts Payable | $5M | $7M | $6M | $6M | $8M | $9M | $6M | $6M | $7M | $5M | $5M | $4M | $4M | $6M | $6M | $3M | |
| Accrued Liabilities | $5M | $9M | $8M | $6M | $6M | $7M | $7M | $6M | $5M | $6M | $6M | $7M | $6M | $6M | $5M | $4M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $7.0K | · | |
| Current Liabilities | $29M | $23M | $27M | $22M | $21M | $21M | $24M | $19M | $17M | $15M | $16M | $14M | $13M | $17M | $13M | $9M | |
| Capital Leases | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $4M | $4M | $5M | $5M | $5M | $4M | $2M | $2M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $192.0K | |
| Total Liabilities | $32M | $25M | $30M | $25M | $24M | $25M | $28M | $22M | $21M | $19M | $21M | $19M | $18M | $20M | $16M | $11M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $59.0K | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $7.0K | · | |
| Common Stock | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | |
| Paid-in Capital | $1.10B | $1.09B | $1.07B | $1.05B | $1.04B | $849M | $837M | $827M | $816M | $809M | $505M | $501M | $497M | $493M | $489M | $356M | |
| Retained Earnings | $-653M | $-595M | $-546M | $-496M | $-455M | $-419M | $-379M | $-339M | $-305M | $-273M | $-215M | $-189M | $-167M | $-145M | $-125M | $-108M | |
| AOCI | $-500.0K | $-252.0K | $677.0K | $701.0K | $204.0K | $401.0K | $420.0K | $1M | $-1M | $-861.0K | $-424.0K | $-547.0K | $-251.0K | $-1M | $-2M | $-2M | |
| Stockholders' Equity | $448M | $493M | $522M | $559M | $589M | $430M | $459M | $489M | $510M | $535M | $290M | $311M | $329M | $347M | $361M | $246M | |
| Liabilities + Equity | $480M | $519M | $553M | $583M | $613M | $454M | $487M | $511M | $532M | $554M | $311M | $331M | $346M | $367M | $377M | $257M | |
| Shares Outstanding | 107,776,380 | 107,481,522 | 106,249,579 | 105,761,949 | 105,341,296 | 95,205,683 | 94,838,466 | 94,408,911 | 93,643,341 | 93,284,528 | 63,460,939 | 63,458,932 | 63,274,732 | 63,257,376 | 63,208,828 | 49,780,365 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $9M | $10M | $8M | $8M | $9M | $8M | $7M | $5M | $5M | $5M | $4M | $4M | $4M | $3M | $2M | |
| Operating Cash Flow | $-42M | $-43M | $-39M | $-35M | $-33M | $-38M | $-27M | $-27M | $-26M | $-29M | $-22M | $-20M | $-23M | $-12M | $-12M | $-16M | |
| CapEx | $32.0K | $260.0K | $73.0K | $89.0K | $50.0K | $44.0K | $274.0K | $520.0K | $221.0K | $297.0K | $457.0K | $759.0K | $4M | $3M | $1M | $554.0K | |
| Investing Cash Flow | $78M | $2M | $50M | $36M | $-162M | $44M | $21M | $25M | $37M | $-268M | $23M | $3M | $49M | $-76M | $-26M | $-46.0K | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | $0 | $239M | · | · | · | $-555.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $239M | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $12M | $4M | $2M | $188M | $2M | $3M | $3M | $2M | $241M | $-211.0K | $369.0K | $21.0K | $-303.0K | $130M | $179.0K | |
| Net Change in Cash | $39M | $-28M | $15M | $3M | $-7M | $8M | $-3M | $1M | $13M | $-56M | $1M | $-16M | $26M | $-88M | $91M | $-16M | |
| Free Cash Flow | · | $-43M | · | · | · | · | · | · | · | $-29M | · | · | $-27M | · | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.5% | -10.1% | · | -7.4% | -6.3% | -8.1% | · | -8.3% | -7.3% | -6.3% | -7.5% | -7.3% | -7.4% | · | -5.2% | -5.7% | |
| ROE | -11.1% | -10.6% | · | -7.8% | -6.6% | -8.5% | · | -8.8% | -7.7% | -6.6% | -7.9% | -7.7% | -7.8% | · | -5.4% | -5.9% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.2 | 22.6 | · | 26.5 | 28.9 | 21.0 | · | 26.3 | 30.2 | 37.1 | 18.2 | 22.0 | 26.2 | · | 27.8 | 27.5 | |
| Quick Ratio | 2.5 | 1.5 | · | 2.1 | 2.1 | 2.4 | · | 2.4 | 2.5 | 2.1 | 2.0 | 2.2 | 3.8 | · | 8.2 | 2.0 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.16 | $4.59 | · | $5.28 | $5.59 | $4.51 | · | $5.18 | $5.45 | $5.73 | $4.58 | $4.91 | $5.20 | · | $5.72 | $4.95 | |
| Cash Flow / Share | · | $-0.40 | · | · | · | $-0.40 | · | · | · | $-0.33 | · | · | $-0.36 | · | · | · | |
| Cash / Share | $0.67 | $0.31 | · | $0.43 | $0.41 | $0.52 | · | $0.47 | $0.46 | $0.32 | $0.52 | $0.50 | $0.76 | · | $1.74 | $0.37 | |
| EPS (TTM) | $-1.85 | $-1.66 | · | $-1.58 | $-1.55 | $-1.55 | · | $-1.49 | $-1.54 | $-1.54 | $-1.41 | $-1.34 | $-1.32 | · | $2.74 | $2.82 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-197M | $-176M | · | $-157M | $-151M | $-146M | · | $-124M | $-116M | $-106M | $-89M | $-81M | $-76M | · | $-61M | $-56M | |
| Market Cap | $4.38B | $3.39B | · | $1.72B | $1.38B | $2.09B | · | $2.52B | $1.69B | $1.70B | $364M | $492M | $422M | · | $622M | $396M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $512M | · | |
| P/E | -22.0 | -19.0 | · | -10.3 | -8.5 | -14.2 | · | -17.9 | -11.7 | -11.8 | -4.1 | -5.8 | -5.1 | · | 3.6 | 2.8 | |
| P/B | 9.8 | 6.9 | · | 3.1 | 2.3 | 4.9 | · | 5.2 | 3.3 | 3.2 | 1.3 | 1.6 | 1.3 | · | 1.7 | 1.6 | |
| P / Tangible Book | 9.8 | 6.9 | · | 3.1 | 2.3 | 4.9 | · | 5.2 | 3.3 | 3.2 | 1.3 | 1.6 | 1.3 | · | 1.7 | 1.6 | |
| P / Cash Flow | · | -79.6 | · | · | · | -55.3 | · | · | · | -59.5 | · | · | -18.5 | · | · | · | |
| Earnings Yield | -4.5% | -5.3% | · | -9.7% | -11.8% | -7.0% | · | -5.6% | -8.6% | -8.4% | -24.6% | -17.3% | -19.8% | · | 27.9% | 35.4% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-168M | $-134M | $-100M | $-68M | $-43M |
| EPS Dilusian | $-1.63 | $-1.45 | $-1.57 | $-1.26 | $-1.14 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 19.9 | 19.9 | 19.5 | 21.5 | 27.0 |
| Rasio Cepat | 2.2 | 1.7 | 5.1 | 1.3 | 1.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-144M | $-110M | $-98M | $-58M | $-34M |
Pemilik institusional (13F) 247 pengaju · $4.9B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
247
Nilai yang dipegang
$4.9B
Posisi baru
41
Posisi yang keluar
25
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 41 (-11 vs Kuartal sebelumnya) | 25 (+2 vs Kuartal sebelumnya) | 85 (+18 vs Kuartal sebelumnya) | 76 (+8 vs Kuartal sebelumnya) | -5.6M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $630.516.330 | 15.518.492 | 12,91% | Saham |
| Paradigm Biocapital Advisors LP | $415.053.937 | 10.215.455 | 8,50% | Saham |
| RA CAPITAL MANAGEMENT, L.P. | $340.996.620 | 8.392.730 | 6,98% | Saham |
| BlackRock, Inc. | $268.415.431 | 6.606.336 | 5,50% | Saham |
| FMR LLC | $223.023.556 | 5.489.135 | 4,57% | Saham |
| NOVO HOLDINGS A/S | $217.370.500 | 5.350.000 | 4,45% | Saham |
| Driehaus Capital Management LLC | $192.123.952 | 4.728.623 | 3,94% | Saham |
| JANUS HENDERSON GROUP PLC | $186.289.082 | 5.915.556 | 3,82% | Saham |
| PERCEPTIVE ADVISORS LLC | $177.714.564 | 4.373.974 | 3,64% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $156.859.022 | 3.860.670 | 3,21% | Saham |
| BAKER BROS. ADVISORS LP | $150.400.843 | 3.701.719 | 3,08% | Saham |
| Siren, L.L.C. | $129.391.476 | 3.184.629 | 2,65% | Saham |
| VANGUARD GROUP INC | $120.889.349 | 4.871.624 | 2,48% | Saham |
| Cormorant Asset Management, LP | $101.981.300 | 2.510.000 | 2,09% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $88.348.054 | 2.174.051 | 1,81% | Saham |
| Integral Health Asset Management, LLC | $81.260.000 | 2.000.000 | 1,66% | Saham |
| BRAIDWELL LP | $81.136.688 | 1.996.965 | 1,66% | Saham |
| MORGAN STANLEY | $79.171.495 | 1.948.597 | 1,62% | Saham |
| STATE STREET CORP | $74.268.674 | 1.827.927 | 1,52% | Saham |
| ALLIANCEBERNSTEIN L.P. | $66.749.256 | 2.119.024 | 1,37% | Saham |
| MPM BIOIMPACT LLC | $65.852.291 | 1.620.780 | 1,35% | Saham |
| BANK OF AMERICA CORP /DE/ | $63.312.105 | 1.558.260 | 1,30% | Saham |
| Qube Research & Technologies Ltd | $50.889.359 | 1.252.507 | 1,04% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $46.309.097 | 1.139.726 | 0,95% | Saham |
| AMERICAN CENTURY COMPANIES INC | $45.793.233 | 1.127.078 | 0,94% | Saham |
| First Light Asset Management, LLC | $44.496.798 | 1.095.171 | 0,91% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $36.683.608 | 902.870 | 0,75% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $31.953.707 | 786.456 | 0,65% | Saham |
| NORTHERN TRUST CORP | $27.273.701 | 671.270 | 0,56% | Saham |
| Aberdeen Group plc | $26.325.233 | 647.926 | 0,54% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25.212.215 | 620.532 | 0,52% | Saham |
| Tyro Capital Management LLC | $24.904.768 | 612.965 | 0,51% | Saham |
| GOLDMAN SACHS GROUP INC | $24.356.425 | 599.469 | 0,50% | Saham |
| Parkman Healthcare Partners LLC | $23.444.973 | 577.036 | 0,48% | Saham |
| Artisan Partners Limited Partnership | $23.359.203 | 574.925 | 0,48% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $22.276.820 | 548.285 | 0,46% | Saham |
| NORGES BANK | $20.726.988 | 510.140 | 0,42% | Saham |
| Opaleye Management Inc. | $20.315.000 | 500.000 | 0,42% | Saham |
| CITADEL ADVISORS LLC | $19.084.196 | 469.707 | 0,39% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $18.771.060 | 462.000 | 0,38% | Saham |
| Soleus Capital Management, L.P. | $18.319.620 | 450.889 | 0,38% | Saham |
| Nuveen, LLC | $16.849.506 | 414.706 | 0,35% | Saham |
| New Leaf Venture Partners, L.L.C. | $16.709.211 | 1.030.161 | 0,34% | Saham |
| Sofinnova Investments, Inc. | $15.476.901 | 380.923 | 0,32% | Saham |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $13.570.989 | 334.014 | 0,28% | Saham |
| RAYMOND JAMES FINANCIAL INC | $12.902.666 | 317.565 | 0,26% | Saham |
| Squadron Capital Management LLC | $11.782.700 | 290.000 | 0,24% | Saham |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $11.511.820 | 283.333 | 0,24% | Saham |
| DIADEMA PARTNERS LP | $11.060.055 | 272.214 | 0,23% | Saham |
| PRUDENTIAL FINANCIAL INC | $10.593.257 | 260.725 | 0,22% | Saham |
Aktivis & pemilik 5%+ 3 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Novo Holdings A/S ×7 pengajuan | 27 April 2026 | 4,90% | Amandemen | · | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VI LLC, OrbiMed Genesis GP LLC, ORBIMED CAPITAL LLC ×5 pengajuan | 12 Mei 2025 | 14,50% | Amandemen | · | SEC |
| U.S. Venture Partners XI, L.P. (“USVP XI”), Presidio Management Group XI, L.L.C. (“PMG XI”), Casey M. Tansey, Jonathan D. Root ×2 pengajuan | 1 Feb. 2023 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 18 orang dalam · 7 pejabat · 8 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Michael Nofi | Chief Financial Officer | 12 Agu 2026 A | · | 0 | 0 | $0 |
| Michael R Carruthers | Chief Financial Officer | 12 Agu 2025 A | 86.162 | 0 | 0 | $0 |
| Alan J Russell | Chief Scientific Officer | 12 Agu 2026 A | 31.466 | 0 | 6 | $-10.252.060 |
| Behrad Derakhshan | Chief Business Officer | 12 Agu 2026 A | 31.826 | 0 | 4 | $-223.420 |
| Joanne M. Donovan | CMO | 12 Agu 2026 A | 8.625 | 0 | 11 | $-4.623.076 |
| Robert Blaustein | Chief Development Officer | 12 Agu 2025 A | · | 0 | 0 | $0 |
| Marc Semigran | Chief Development Officer | 24 Des. 2024 M | 6.716 | 0 | 0 | $0 |
| Jonathan C Fox | Direktur | 1 Okt. 2026 A | 25.141 | 1 | 0 | $199.448 |
| Christopher Nathan Martin | Direktur | 5 Juni 2026 A | · | 0 | 0 | $0 |
| Badreddin Edris | Direktur | 5 Juni 2026 A | 19.820 | 0 | 5 | $-3.399.467 |
| Laura Brege | Direktur | 5 Juni 2026 A | · | 0 | 0 | $0 |
| Arlene Morris | Direktur | 5 Juni 2026 A | · | 0 | 0 | $0 |
| Peter A. Thompson | Direktur | 5 Juni 2026 A | 443.792 | 0 | 0 | $0 |
| Jonathan D Root | Direktur | 5 Juni 2026 A | 0 | 0 | 0 | $0 |
| Novo Holdings A/S | Pemilik 10% | 14 Sep. 2022 P | 6.071.703 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Pemilik 10% | 30 Maret 2021 C | 681.812 | 0 | 0 | $0 |
| John R Moore | · | 12 Agu 2026 A | 17.697 | 0 | 4 | $-219.831 |
| Kevin Koch | · | 12 Agu 2026 A | 52.488 | 0 | 3 | $-785.049 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 35 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IBRN · iShares Trust | 3,53% | 6.153 SH | 11 Sep. 2026 | Harian |
| PTH · Invesco Exchange-Traded Fund Trust | 1,36% | 96.973 SH | 2 Okt. 2026 | Harian |
| PILL · Direxion Shares ETF Trust | 1,33% | 7.137 NS | 31 Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,74% | 8.925 NS | 31 Juli 2026 | N-PORT |
| IHE · iShares Trust | 0,74% | 278.770 SH | 11 Sep. 2026 | Harian |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,35% | 35.134 SH | 2 Okt. 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,29% | 7.672 SH | 2 Okt. 2026 | Harian |
| IBB · iShares Trust | 0,25% | 599.006 SH | 11 Sep. 2026 | Harian |
| IWO · iShares Trust | 0,20% | 671.171 SH | 11 Sep. 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,17% | 76.681 SH | 19 Agu 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,13% | 65.171 SH | 19 Agu 2026 | Harian |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 23.462 NS | 31 Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,11% | 2.494 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,10% | 1.832.689 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 411.642 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,09% | 34.242 NS | 31 Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,06% | 14.090 SH | 10 Sep. 2026 | Harian |
| ESML · iShares Trust | 0,05% | 33.329 SH | 11 Sep. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,04% | 168.775 NS | 31 Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 24.755 SH | 2 Okt. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 864.416 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,03% | 145.298 SH | 19 Agu 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 22.934 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 3.133 SH | 9 Sep. 2026 | Harian |
| TILT · FlexShares Trust | 0,01% | 6.190 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 2.902.915 SH | 19 Agu 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,01% | 103.617 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 5.796 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 105.809 SH | 11 Sep. 2026 | Harian |
| DFAU · Dimensional ETF Trust | 0,00% | 15.310 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 21.128 SH | 10 Sep. 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,00% | 9.509 NS | 31 Juli 2026 | N-PORT |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.890 SH | 19 Agu 2026 | Harian |
| ISCB · iShares Trust | · | 3.892 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 9.439 SH | 11 Sep. 2026 | Harian |
EWTX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 19 analis
BELI
Target median
$53.00
+28,0%
7 36,8%
Beli Kuat
9 47,4%
Beli
3 15,8%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
13 analis · 2026-09-29Target rata-rata $52.62 +27,1%
Sekarang
Harga saat ini $41.40
Rendah$36.00
Rata-rata$52.62
Tinggi$66.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| EWTX | $2.64B | -15.2 | · | · | -30.2% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| LGND | $3.74B | 30.8 | 60.4% | 46.4% | 13.5% | · |
| DFTX | $1.32B | -6.5 | 212.0% | · | -71.0% | · |
| MANE | · | · | · | · | 82.6% | · |
| INDV | · | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| AMLX | $1.33B | -7.9 | -77.1% | · | -61.2% | · |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | · |
| ELVN | $915M | -8.4 | · | · | -21.9% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026